beta

TLRY

Tilray Brands Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.

Market Cap: 1.21 Billion

Primary Exchange: NASDAQ

Website: https://www.tilray.com/

Shares Outstanding: 743 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.5613484606542958

Sector: Manufacturing

Industry: Medicinal and Botanical Manufacturing

Ethical Flags

Longest drawdown: 1955 trading days

From: 2018-09-19 To: 2024-03-07

Lowest Point:

Health Canada briefing tomorrow on next steps in weed regulation

via: SeekingAlpha at 2019-06-13 13:01:05:000

Health Canada officials will hold a media briefing tomorrow, June 14, at 12:30 pm ET to discuss the next steps in the legalization and regulation of cannabis there. More news on: Tilray, Inc., Aurora Cannabis Inc., Cronos Group Inc., Healthcare stocks news, Consumer stocks news, News on ET… read more...

Tilray® Expands Global Senior Leadership Team with the Appointment of Kristina Adamski as EVP of Corporate Affairs

via: Business Wire at 2019-06-13 05:00:00:000

Former Nissan North America Vice President Kristina Adamski joins Tilray to lead the companys global corporate affairs team Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production, research, cultivation and distribution, today announced the expansion of its globa… read more...

Tilray: An Irrational Reaction

via: SeekingAlpha at 2019-06-12 09:01:11:000

Financial engineering can be a wonderful tool used by the management teams of firms in order to create value. In the past, for instance, I have talked about some of the innovative financing transactions of cannabis giant Aurora Cannabis ( ACB ) that allowed the company to grow on terms i… read more...

Cannabis And Alcohol Beverage Industries Are On A Collision Course, With Ted Dumbauld (Podcast)

via: SeekingAlpha at 2019-06-12 03:00:35:000

Listen on the go! Subscribe to The Cannabis Investing Podcast on Libsyn , Spotify , Stitcher or Apple Podcasts . By Rena Sherbill Today, I am very happy to be joined by Ted Dumbauld, Chief Operating Officer of Curio Wellness , a vertically integr… read more...

Short Selling Recent IPOs

via: SeekingAlpha at 2019-06-10 12:38:36:000

Recent IPOs have drawn substantial interest from short sellers for a variety of reasons. The most anticipated IPOs of the year by longs and shorts were the ride hailing apps Uber (UBER) and Lyft (LYFT). On the first settlement day following Lyft's IPO, it was briefly the most expensive to borr… read more...

Short Selling Recent IPOs

via: SeekingAlpha at 2019-06-10 12:38:36:000

Recent IPOs have drawn substantial interest from short sellers for a variety of reasons. The most anticipated IPOs of the year by longs and shorts were the ride hailing apps Uber (UBER) and Lyft (LYFT). On the first settlement day following Lyft's IPO, it was briefly the most expensive to borr… read more...

Tilray up 1% after hours on expanded Valens partnership

via: SeekingAlpha at 2019-06-10 12:29:09:000

Tilray (NASDAQ: TLRY ) perks up 1% after hours on the heels of its expanded agreement with Valens GroWorks for extraction, distillation, cannabinoid isolation and purification services. More news on: Tilray, Inc., Healthcare stocks news, Consumer stocks news, Stocks on the mo… read more...

Tilray up 1% after hours on expanded Valens partnership

via: SeekingAlpha at 2019-06-10 12:29:09:000

Tilray (NASDAQ: TLRY ) perks up 1% after hours on the heels of its expanded agreement with Valens GroWorks for extraction, distillation, cannabinoid isolation and purification services. More news on: Tilray, Inc., Healthcare stocks news, Consumer stocks news, Stocks on the mo… read more...

Presumed positive effect of cannabis consumption on opioid overdose deaths not there

via: SeekingAlpha at 2019-06-10 11:46:11:000

A just-published study has contradicted the findings of an early one that implied a connection between the availability of legal marijuana and opioid overdose deaths. More news on: Tilray, Inc., Cronos Group Inc., Canopy Growth Corporation, Healthcare stocks news, Consumer stocks news, Sto… read more...

Presumed positive effect of cannabis consumption on opioid overdose deaths not there

via: SeekingAlpha at 2019-06-10 11:46:11:000

A just-published study has contradicted the findings of an early one that implied a connection between the availability of legal marijuana and opioid overdose deaths. More news on: Tilray, Inc., Cronos Group Inc., Canopy Growth Corporation, Healthcare stocks news, Consumer stocks news, Sto… read more...

Church of England on board with medical cannabis investments

via: SeekingAlpha at 2019-06-10 05:27:29:000

The Financial Times reports that the Church of England has given its investment arm the green light to invest in medical marijuana, a reversal of previous policy. More news on: Tilray, Inc., Aurora Cannabis Inc., Canopy Growth Corporation, Healthcare stocks news, Consumer stocks news, Ne… read more...

Church of England on board with medical cannabis investments

via: SeekingAlpha at 2019-06-10 05:27:29:000

The Financial Times reports that the Church of England has given its investment arm the green light to invest in medical marijuana, a reversal of previous policy. More news on: Tilray, Inc., Aurora Cannabis Inc., Canopy Growth Corporation, Healthcare stocks news, Consumer stocks news, Ne… read more...

MNKD, DATA among premarket gainers

via: SeekingAlpha at 2019-06-10 05:13:59:000

Provention Bio (NASDAQ: PRVB ) +170% on potential of teplizumab to delay diabetes. More news on: Provention Bio, Inc., Tableau Software, Inc., Tilray, Inc., Stocks on the move, Read more … read more...

MNKD, DATA among premarket gainers

via: SeekingAlpha at 2019-06-10 05:13:59:000

Provention Bio (NASDAQ: PRVB ) +170% on potential of teplizumab to delay diabetes. More news on: Provention Bio, Inc., Tableau Software, Inc., Tilray, Inc., Stocks on the move, Read more … read more...

Tilray, Inc. and Privateer Holdings, Inc. Sign Letter of Intent to Extend Lock-up and Provide for Orderly Release of 75 Million Tilray Shares Held by Privateer

via: Business Wire at 2019-06-10 02:00:00:000

Lock-up to be Extended for up to Two Years on 77 Percent of Tilrays Total Shares Outstanding Transaction Expected to be Tax-Efficient for Privateer Stockholders Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production, and distribution, to… read more...

Tilray, Inc. and Privateer Holdings, Inc. Sign Letter of Intent to Extend Lock-up and Provide for Orderly Release of 75 Million Tilray Shares Held by Privateer

via: Business Wire at 2019-06-10 02:00:00:000

Lock-up to be Extended for up to Two Years on 77 Percent of Tilrays Total Shares Outstanding Transaction Expected to be Tax-Efficient for Privateer Stockholders Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production, and distribution, to… read more...

Medicine Man Technologies: Positioned For Growth

via: SeekingAlpha at 2019-06-09 13:56:02:000

Medicine Man Technologies ( MDCL ) is a cannabis company that produces and distributes marijuana-based products. Located in Colorado, their products range from medicinal use to recreational over a variety of different forms. However, product sales are only a fraction of revenue. Medicine Man T… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud